Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Identify essential line items for unexpected bills and set aside funds to smooth out financial shocks. A clear plan reduces anxiety and keeps spending in check.
15,931 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Nike just 11-year low signals a pivotal moment for the brand and its investors. This article breaks down what's weigh...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...
Fiverr International sits near a 52-week low, inviting questions about its future. This article breaks down the busin...
A potential Dow reshuffle could end Nike's long run in the index and swap it for a consumer-facing giant. This articl...
Fortinet sits at the center of a rapidly expanding cybersecurity market. This article explains why fortinet: strong i...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
Big AI-driven demand is reshaping data-center stocks. Terawulf and IREN rallied as investors priced in new compute ca...
A new wave of tech IPOs is poised to influence index funds and passive strategies. Learn what it means for your portf...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
As the financial world evolves, investors must choose between broad sector exposure and a regional bank niche. This g...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...